Scholars Central

Short communicationPublished 22 Oct 2021

Paraneoplastic Antigens as Biomarkers for Early Detection and Prediction of Recurrence of the Ovarian Cancer

Authors: Michael A Tainsky

Reproductive Immunology: Open Access

Volume 5 · Issue 5 · Pages 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Routine disease monitoring of ovarian cancer patients is generally recommended by gynecologic oncologists for women from high-risk families and for ovarian cancer patients after the completion of primary surgery and first-line chemotherapeutic treatments. The recurrence is determined by measuring the level of serum CA125, one of the most extensively used tumor biomarkers in standard clinical practice for disease surveillance. Numerous studies have shown the role of tumor autoantibodies as biomarkers for ovarian cancer diagnosis and its recurrence. These autoantibodies to tumor-associated antigens (TAAs) arise due to the generation of humoral immune response before evidence of clinical symptoms in cancer patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalReproductive Immunology: Open Access
  • SubjectImmunology & Microbiology
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Michael A Tainsky”